Literature DB >> 17582657

Deglycosylation and subcellular redistribution of VMAT2 in the mesostriatal system during normal aging.

Ignacio Cruz-Muros1, Domingo Afonso-Oramas, Pedro Abreu, Manuel Rodríguez, M Carmen González, Tomás González-Hernández.   

Abstract

The vesicular monoamine transporter type 2 (VMAT2) is a transmembrane glycoprotein responsible for the vesicular monoamine uptake in the brain. This function declines in the dopaminergic mesostriatal system during normal aging, but the mechanisms responsible for this deficit are unknown. We investigated possible age-related changes in the expression and subcellular distribution of VMAT2 in the rat mesostriatal system. VMAT2 is constitutively expressed as glycosylated (75 kDa), partially glycosylated (55 kDa) and native (45 kDa) forms, they are all present in both synaptosomal compartments (synaptosomal membrane and synaptic vesicle-enriched fractions) of the striatal terminals in young rats. In aged rats, no changes were found in midbrain VMAT2mRNA and VMAT2 total protein levels in whole striatal extracts. However, its subcellular distribution and glycosylation pattern were severely modified. The three VMAT2 forms virtually disappeared from the synaptic vesicle-enriched fraction, while the 55 kDa form was accumulated in the soluble compartment. These changes may be responsible for the loss of VMAT2 activity during aging and may contribute to the high susceptibility of aged midbrain dopaminergic cells to degeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582657     DOI: 10.1016/j.neurobiolaging.2007.04.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

Review 1.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

2.  Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.

Authors:  Tonya N Taylor; Shawn P Alter; Minzheng Wang; David S Goldstein; Gary W Miller
Journal:  Neuropharmacology       Date:  2013-09-08       Impact factor: 5.250

3.  Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

Authors:  Rachel A Cliburn; Amy R Dunn; Kristen A Stout; Carlie A Hoffman; Kelly M Lohr; Alison I Bernstein; Emily J Winokur; James Burkett; Yvonne Schmitz; William M Caudle; Gary W Miller
Journal:  J Chem Neuroanat       Date:  2016-11-09       Impact factor: 3.052

4.  Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat.

Authors:  Courtney M Keller; Michael F Salvatore; Brandon S Pruett; Glenn F Guerin; Nicholas E Goeders
Journal:  Psychopharmacology (Berl)       Date:  2011-04-27       Impact factor: 4.530

5.  Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies.

Authors:  Junchao Tong; Isabelle Boileau; Yoshiaki Furukawa; Li-Jan Chang; Alan A Wilson; Sylvain Houle; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-27       Impact factor: 6.200

6.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

Review 7.  Trafficking of vesicular neurotransmitter transporters.

Authors:  Hao Fei; Anna Grygoruk; Elizabeth S Brooks; Audrey Chen; David E Krantz
Journal:  Traffic       Date:  2008-05-26       Impact factor: 6.215

8.  Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury.

Authors:  Steven M Markos; Michelle D Failla; Anne C Ritter; C Edward Dixon; Yvette P Conley; Joseph H Ricker; Patricia M Arenth; Shannon B Juengst; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2017 Mar/Apr       Impact factor: 2.710

Review 9.  Parkinson's disease as a result of aging.

Authors:  Manuel Rodriguez; Clara Rodriguez-Sabate; Ingrid Morales; Alberto Sanchez; Magdalena Sabate
Journal:  Aging Cell       Date:  2015-02-09       Impact factor: 9.304

10.  Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples.

Authors:  Jennifer N K Nyarko; Maa O Quartey; Ryan M Heistad; Paul R Pennington; Lisa J Poon; Kaeli J Knudsen; Odette Allonby; Amr M El Zawily; Andrew Freywald; Gail Rauw; Glen B Baker; Darrell D Mousseau
Journal:  Front Neurosci       Date:  2018-08-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.